BRNS
Barinthus Biotherapeutics plc
NASDAQ: BRNS · HEALTHCARE · BIOTECHNOLOGY
$0.60
-1.66% today
Updated 2026-04-29
Market cap
$26.23M
P/E ratio
—
P/S ratio
2.17x
EPS (TTM)
$-1.64
Dividend yield
—
52W range
$1 – $3
Volume
0.0M
Barinthus Biotherapeutics plc (BRNS) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-65.00%
ROA
-28.10%
Debt/equity
0.14x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2019 | $6.85M | $-20.73M | -335.97% | -374.94% | -302.84% |
| 2020 | $4.82M | $-17.71M | -198.42% | -415.81% | -367.27% |
| 2021 | $268000.00 | $-50.87M | 100.00% | -16,873.51% | -18,979.48% |
| 2022 | $44.70M | $5.34M | 100.00% | -9.04% | 11.95% |
| 2023 | $802000.00 | $-73.35M | 100.00% | -10,463.09% | -9,145.51% |
| 2024 | $14.97M | $-61.07M | 100.00% | -454.07% | -408.00% |
| 2025 | $0.00 | $-66.43M | — | — | — |